Trial Outcomes & Findings for Increasing Naloxone Access for Persons Who Use Opioids (NCT NCT04303000)

NCT ID: NCT04303000

Last Updated: 2023-10-30

Results Overview

Feasibility of online opioid overdose education and remote naloxone distribution as indicated by recruitment of at least 80 total participants in 6 months. There was not a calculated measure, and this aspect of feasibility was based on ability to recruit a set number of participants in a predetermined amount of time.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

111 participants

Primary outcome timeframe

6 months

Results posted on

2023-10-30

Participant Flow

Participants were recruited via online social media platforms (e.g., Craigslist) between July and October 2021.

A total of 13 participants were not randomized to a group for the training portion of the study, as they did not complete the baseline assessment.

Participant milestones

Participant milestones
Measure
Screened Participants
Started and completed screening
Opioid Overdose Education and Naloxone Distribution
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm were provided with a naloxone nasal spray kit (4mg). Opioid Overdose Education with Naloxone Distribution: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with a naloxone kit.
Opioid Overdose Education
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm received information about pharmacies in their area where they could purchase a naloxone kit. Opioid Overdose Education: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with information on where they could obtain a naloxone kit.
Opioid Use Questionnaire
STARTED
319
0
0
Opioid Use Questionnaire
COMPLETED
304
0
0
Opioid Use Questionnaire
NOT COMPLETED
15
0
0
Training Portion
STARTED
0
55
56
Training Portion
Month 1 Follow-Up
0
48
50
Training Portion
Month 2 Follow-Up
0
48
50
Training Portion
Month 3 Follow-Up
0
47
48
Training Portion
COMPLETED
0
45
47
Training Portion
NOT COMPLETED
0
10
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Screened Participants
Started and completed screening
Opioid Overdose Education and Naloxone Distribution
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm were provided with a naloxone nasal spray kit (4mg). Opioid Overdose Education with Naloxone Distribution: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with a naloxone kit.
Opioid Overdose Education
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm received information about pharmacies in their area where they could purchase a naloxone kit. Opioid Overdose Education: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with information on where they could obtain a naloxone kit.
Opioid Use Questionnaire
Withdrawal by Subject
15
0
0

Baseline Characteristics

Increasing Naloxone Access for Persons Who Use Opioids

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Opioid Overdose Education and Naloxone Distribution
n=55 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm were provided with a naloxone nasal spray kit (4mg). Opioid Overdose Education with Naloxone Distribution: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with a naloxone kit.
Opioid Overdose Education
n=56 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm received information about pharmacies in their area where they could purchase a naloxone kit. Opioid Overdose Education: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with information on where they could obtain a naloxone kit.
Total
n=111 Participants
Total of all reporting groups
Age, Continuous
37.44 years
STANDARD_DEVIATION 9.08 • n=93 Participants
38.54 years
STANDARD_DEVIATION 10.54 • n=4 Participants
37.93 years
STANDARD_DEVIATION 9.76 • n=27 Participants
Sex: Female, Male
Female
35 Participants
n=93 Participants
34 Participants
n=4 Participants
69 Participants
n=27 Participants
Sex: Female, Male
Male
20 Participants
n=93 Participants
22 Participants
n=4 Participants
42 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=93 Participants
2 Participants
n=4 Participants
4 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants
n=93 Participants
54 Participants
n=4 Participants
107 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=93 Participants
7 Participants
n=4 Participants
12 Participants
n=27 Participants
Race (NIH/OMB)
White
46 Participants
n=93 Participants
45 Participants
n=4 Participants
91 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=93 Participants
4 Participants
n=4 Participants
7 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Region of Enrollment
United States
55 Participants
n=93 Participants
56 Participants
n=4 Participants
111 Participants
n=27 Participants

PRIMARY outcome

Timeframe: 6 months

Feasibility of online opioid overdose education and remote naloxone distribution as indicated by recruitment of at least 80 total participants in 6 months. There was not a calculated measure, and this aspect of feasibility was based on ability to recruit a set number of participants in a predetermined amount of time.

Outcome measures

Outcome measures
Measure
Opioid Overdose Education and Naloxone Distribution
n=55 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm were provided with a naloxone nasal spray kit (4mg). Opioid Overdose Education with Naloxone Distribution: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with a naloxone kit.
Opioid Overdose Education
n=56 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm received information about pharmacies in their area where they could purchase a naloxone kit. Opioid Overdose Education: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with information on where they could obtain a naloxone kit.
The Number of Participants That Completed the Training in 6 Months
Enrolled and Randomized
55 Participants
56 Participants
The Number of Participants That Completed the Training in 6 Months
Lost to Follow-up
10 Participants
9 Participants

PRIMARY outcome

Timeframe: 6 months

Mean change in participant knowledge as indicated by difference in scores on pre- and post-training knowledge questionnaires on a scale of 1 to 9 where 9 indicates greater knowledge.

Outcome measures

Outcome measures
Measure
Opioid Overdose Education and Naloxone Distribution
n=55 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm were provided with a naloxone nasal spray kit (4mg). Opioid Overdose Education with Naloxone Distribution: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with a naloxone kit.
Opioid Overdose Education
n=56 Participants
Participants engaged in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm received information about pharmacies in their area where they could purchase a naloxone kit. Opioid Overdose Education: Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants were provided with information on where they could obtain a naloxone kit.
Change in Participant Knowledge of Opioid Overdose Response Procedures
1.48 score on a scale
Standard Deviation 1.83
1.34 score on a scale
Standard Deviation 1.51

Adverse Events

Opioid Overdose Education and Naloxone Distribution

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Opioid Overdose Education

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Melinda Clarke

University of Alabama at Birmingham

Phone: 205-975-7809

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place